Modern issues in bone graft substitutes and advances in bone tissue technology

Area of Science:

• Orthopedic surgery
• Biomaterials science
• Regenerative medicine

Background:

• Autogenous bone grafting is the gold standard for bony defect repair, fracture nonunion, and arthrodesis.
• Significant complications can arise from harvesting autogenous grafts, driving the need for alternative materials.
• The orthopedic market offers various augmentation and substitution materials, including allografts, demineralized bone matrix (DBM) products, and calcium-based ceramics.

Purpose of the Study:

• To review the current landscape of bone grafting materials.
• To highlight the efficacy and limitations of available bone graft substitutes.
• To discuss emerging technologies in bone regeneration.

Main Methods:

• Review of current literature on bone graft materials.
• Analysis of the properties and applications of allografts, DBM products, calcium-based ceramics, and composite materials.
• Discussion of novel approaches including recombinant human bone morphogenic proteins, growth factors, and autogenous stem cells.

Main Results:

• Allograft effectiveness is high, but tissue processing is critical to preserve osteoinductive and structural capacities.
• Demineralized bone matrix (DBM) products face regulatory concerns regarding product activity and efficacy.
• Calcium-based ceramics are effective osteoconductive agents for bone void filling; augmentation with osteoinductive materials is recommended for nonunions and arthrodesis.

Conclusions:

• While autogenous bone grafts remain the gold standard, allografts and ceramic materials offer viable alternatives with specific considerations.
• Careful selection of tissue sources and processing methods for allografts is essential.
• Emerging technologies, including recombinant proteins, growth factors, and stem cell therapies, represent the future of bone grafting procedures.